Palladiem, LLC filed a Form 13F-HR on November 9, 2026, disclosing its equity holdings as of September 30, 2026. The filing lists 134 separate positions held by the firm, managed by Chief Investment Officer Donald Robinson, who is based in Bryn Mawr, Pennsylvania.
The portfolio is diversified across a wide range of sectors, with technology and healthcare companies representing a significant portion of the holdings. Major technology positions include Apple Inc., Microsoft Corporation, NVIDIA Corporation, Broadcom Inc., and Advanced Micro Devices Inc. The portfolio also includes substantial stakes in healthcare entities such as Abbott Laboratories, Amgen Inc., Eli Lilly & Co., and Gilead Sciences Inc.
In addition to individual stocks, the filing reveals significant exposure to exchange-traded funds (ETFs). The portfolio holds shares in the SPDR S&P 500 ETF Trust, the iShares Core U.S. Aggregate Bond ETF, and the iShares Bitcoin Trust ETF. Other notable holdings include shares of Berkshire Hathaway Inc., JPMorgan Chase & Co., and Visa Inc.
